Elsevier

The Lancet

Volume 327, Issue 8474, 25 January 1986, Pages 218-219
The Lancet

Letters to the Editor
SOMATOMEDIN C IN PATHOGENESIS OF MALIGNANT EXOPHTHALMOS OF ENDOCRINE ORIGIN

https://doi.org/10.1016/S0140-6736(86)90698-7Get rights and content

References (7)

  • Rc Sergott et al.

    Graves' ophthalmology: a clinical and immunologic review

    Survey Ophthalmol

    (1981)
  • Dh Jacobson et al.

    Endocrine ophthalmopathy: Current ideas concerning etiology, pathogenesis and treatment

    Endocrinol Rev

    (1985)
  • Jh Ogula et al.

    Orbital decompression for exophthalmos

    Otaryngol Clins N Am

    (1980)
There are more references available in the full text version of this article.

Cited by (48)

  • Insulin-like growth factor 1 promotes the proliferation and adipogenesis of orbital adipose-derived stromal cells in thyroid-associated ophthalmopathy

    2013, Experimental Eye Research
    Citation Excerpt :

    Insulin-like growth factor 1 (IGF-1) is a polypeptide, the expression of which in most tissue is known to regulate adipose tissue mass through its regulation of adipogenesis (Grohmann et al., 2005; Smith et al., 1988). A number of studies have demonstrated that IGF-1 levels were increased in samples of eye fat and muscle, which were obtained after decompression surgery from patients with TAO (Hansson et al., 1986; Matos et al., 2008). Local production of IGF-1 by orbital fibroblasts was elevated in TAO patients (Song et al., 2012).

  • Retro-orbital autoimmunity

    1997, Bailliere's Clinical Endocrinology and Metabolism
  • Possible targets for nonimmunosuppressive therapy of graves' orbitopathy

    2014, Journal of Clinical Endocrinology and Metabolism
View all citing articles on Scopus
View full text